{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:28:06Z","timestamp":1778203686723,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cca.2023.117323","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T17:46:41Z","timestamp":1680198401000},"page":"117323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Aberrant glycosylation of \u03b13 integrins as diagnostic markers in epithelial ovarian cancer"],"prefix":"10.1016","volume":"543","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0748-6050","authenticated-orcid":false,"given":"Shruti","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadharshini","family":"Parimelazhagan Santhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rufus","family":"Vinod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamima","family":"Afrin Ruma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Huhtinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Pettersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Sundfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Leivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh","family":"Gidwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117323_b0005","doi-asserted-by":"crossref","unstructured":"van Nagell JR, Jr., Hoff JT. Transvaginal ultrasonography in ovarian cancer screening: current perspectives. Int J Womens Health. 2013; 6: 25-33.","DOI":"10.2147\/IJWH.S38347"},{"key":"10.1016\/j.cca.2023.117323_b0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.cca.2023.117323_b0015","doi-asserted-by":"crossref","unstructured":"Scholler N, Urban N. CA125 in Ovarian Cancer. Biomarkers in medicine. 2007; 1: 513-23. https:\/\/doi. org\/10.2217\/17520363.1.4.513.","DOI":"10.2217\/17520363.1.4.513"},{"issue":"4","key":"10.1016\/j.cca.2023.117323_b0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1074\/mcp.M800313-MCP200","article-title":"Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers","volume":"8","author":"Kuk","year":"2009","journal-title":"Mol Cell Proteomics."},{"issue":"1","key":"10.1016\/j.cca.2023.117323_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/00016340802443830","article-title":"Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology","volume":"88","author":"Petri","year":"2009","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"3","key":"10.1016\/j.cca.2023.117323_b0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/prca.200900042","article-title":"Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis","volume":"4","author":"Petri","year":"2010","journal-title":"Proteomics Clin Appl."},{"issue":"1","key":"10.1016\/j.cca.2023.117323_b0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/pr0703223","article-title":"A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers","volume":"7","author":"Gortzak-Uzan","year":"2008","journal-title":"J Proteome Res."},{"key":"10.1016\/j.cca.2023.117323_b0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1559-0275-9-14","article-title":"Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers","volume":"9","author":"Kristjansdottir","year":"2012","journal-title":"Clin Proteom"},{"issue":"1A","key":"10.1016\/j.cca.2023.117323_b0045","first-page":"65","article-title":"Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts","volume":"21","author":"Sundfeldt","year":"2001","journal-title":"Anticancer Res."},{"issue":"15","key":"10.1016\/j.cca.2023.117323_b0050","first-page":"3294","article-title":"Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer","volume":"58","author":"Wahlberg","year":"1998","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cca.2023.117323_b0055","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1006\/gyno.1998.5198","article-title":"The chemotactic cytokine interleukin-8-a cyst fluid marker for malignant epithelial ovarian cancer?","volume":"71","author":"Ivarsson","year":"1998","journal-title":"Gynecol Oncol."},{"issue":"21","key":"10.1016\/j.cca.2023.117323_b0060","first-page":"7507","article-title":"Calgranulins in cystic fluid and serum from patients with ovarian carcinomas","volume":"63","author":"Ott","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.cca.2023.117323_b0065","unstructured":"Sato, M. et al. Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer. Oncol. Lett. 15, 1357\u20131361. https:\/\/ doi. org\/ 10. 3892\/ ol. 2017. 7388 (2018)."},{"key":"10.1016\/j.cca.2023.117323_b0070","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1074\/mcp.M114.041194","article-title":"Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication","volume":"13","author":"Shender","year":"2014","journal-title":"Mol Cell Proteomics."},{"issue":"12","key":"10.1016\/j.cca.2023.117323_b0075","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.2147\/CMAR.S228288","article-title":"A Polyethylene Glycol-Based Method for Enrichment of Extracellular Vesicles from Culture Supernatant of Human Ovarian Cancer Cell Line A2780 and Body Fluids of High-Grade Serous Carcinoma Patients","volume":"24","author":"Jiao","year":"2020","journal-title":"Cancer Manag Res."},{"issue":"9","key":"10.1016\/j.cca.2023.117323_b0080","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.yexcr.2008.09.020","article-title":"Trafficking and function of the tetraspanin CD63","volume":"315","author":"Pols","year":"2009","journal-title":"Exp Cell Res."},{"issue":"11","key":"10.1016\/j.cca.2023.117323_b0085","first-page":"2955","article-title":"Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression","volume":"48","author":"Hotta","year":"1988","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.cca.2023.117323_b0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1476-4598-13-134","article-title":"RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy","volume":"31","author":"Tominaga","year":"2014","journal-title":"Mol Cancer."},{"key":"10.1016\/j.cca.2023.117323_b0095","doi-asserted-by":"crossref","unstructured":"Liu WH, Li X, Zhu XL, Hou ML, Zhao W. CD63 inhibits the cell migration and invasion ability of tongue squamous cell carcinoma. Oncol Lett. 2018 Jun;15(6):9033-9042. doi: 10.3892\/ol.2018.8499. Epub 2018 Apr 16. PMID: 29844819; PMCID: PMC5958804.","DOI":"10.3892\/ol.2018.8499"},{"issue":"5","key":"10.1016\/j.cca.2023.117323_b0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ijc.2910620523","article-title":"Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491)","volume":"62","author":"Radford","year":"1995","journal-title":"Int J Cancer."},{"issue":"2","key":"10.1016\/j.cca.2023.117323_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","article-title":"Role of integrins in cell invasion and migration","volume":"2","author":"Hood","year":"2002","journal-title":"Nat Rev Cancer."},{"issue":"9","key":"10.1016\/j.cca.2023.117323_b0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat Rev Cancer."},{"issue":"2","key":"10.1016\/j.cca.2023.117323_b0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/proteomes7020014","article-title":"Extracellular Vesicle Integrins Distinguish Unique Cancers","volume":"7","author":"Hurwitz","year":"2019","journal-title":"Proteomes."},{"issue":"9","key":"10.1016\/j.cca.2023.117323_b0120","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat Rev Cancer."},{"issue":"7","key":"10.1016\/j.cca.2023.117323_b0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tibs.2015.04.004","article-title":"Glycan variation and evolution in the eukaryotes","volume":"40","author":"Corfield","year":"2015","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.cca.2023.117323_b0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/B:GLYC.0000043741.47559.30","article-title":"Regulation of integrin functions by N-glycans","volume":"21","author":"Gu","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.cca.2023.117323_b0135","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1248\/bpb.32.780","article-title":"Importance of N-glycosylation on alpha5beta1 integrin for its biological functions","volume":"32","author":"Gu","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cca.2023.117323_b0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bbagen.2010.03.013","article-title":"Cell migration-the role of integrin glyco-sylation","volume":"1800","author":"Janik","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.cca.2023.117323_b0145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.trecan.2018.05.009","article-title":"Glycosylation and Integrin Regulation in Cancer","volume":"4","author":"Marsico","year":"2018","journal-title":"Trends Cancer."},{"key":"10.1016\/j.cca.2023.117323_b0150","doi-asserted-by":"crossref","unstructured":"Radhakrishnan, P. et al. (2014) Immature truncated O-glycophe-notype of cancer directly induces oncogenic features. Proc. Natl. Acad. Sci. U. S. A. 111, E4066\u2013E4075.","DOI":"10.1073\/pnas.1406619111"},{"key":"10.1016\/j.cca.2023.117323_b0155","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1373\/clinchem.2016.257691","article-title":"A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources","volume":"62","author":"Gidwani","year":"2016","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.cca.2023.117323_b0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1373\/jalm.2018.028266","article-title":"Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources","volume":"4","author":"Gidwani","year":"2019","journal-title":"J Appl Lab Med."},{"key":"10.1016\/j.cca.2023.117323_b0165","doi-asserted-by":"crossref","unstructured":"Jain S, Nadeem N, Ulfenborg B, M\u00e4kel\u00e4 M, Ruma SA, Ter\u00e4v\u00e4 J, Huhtinen K, Leivo J, Kristjansdottir B, Pettersson K, Sundfeldt K, Gidwani K. Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer. Int J Cancer. 2022 Oct 1;151(7):1175-1184. doi: 10.1002\/ijc.34111. Epub 2022 May 25. PMID: 35531590; PMCID: PMC9546485.","DOI":"10.1002\/ijc.34111"},{"issue":"628","key":"10.1016\/j.cca.2023.117323_b0170","article-title":"Detection of bladder cancer with aberrantly fucosylated ITGA3","volume":"1","author":"Islam","year":"2021","journal-title":"Anal Biochem."},{"key":"10.1016\/j.cca.2023.117323_b0175","doi-asserted-by":"crossref","unstructured":"Ter\u00e4v\u00e4 J, Verhassel A, Botti O, Islam MK, Leivo J, Wittfooth S, H\u00e4rk\u00f6nen P, Pettersson K, Gidwani K. Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum. Cancer Rep (Hoboken). 2022 Aug;5(8):e1540. doi: 10.1002\/cnr2.1540. Epub 2021 Aug 22. PMID: 34423573; PMCID: PMC9351655.","DOI":"10.1002\/cnr2.1540"},{"key":"10.1016\/j.cca.2023.117323_b0180","doi-asserted-by":"crossref","unstructured":"Wang Y, Sundfeldt K, Mateoiu C, Shih I, Kurman RJ, Schaefer J, Silliman N, Kinde I, Springer S, Foote M, Kristjansdottir B, James N, Kinzler KW, Papadopoulos N, Diaz LA, Vogelstein B. Diagnostic potential of tumor DNA from ovarian cyst fluid. eLife 2016; 5.","DOI":"10.7554\/eLife.15175"},{"issue":"10","key":"10.1016\/j.cca.2023.117323_b0185","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/ac001287l","article-title":"Utilization of kinetically enhanced monovalent binding affinity by immunoassays based on multivalent nanoparticle-antibody bioconjugates","volume":"73","author":"Soukka","year":"2001","journal-title":"Anal Chem."},{"key":"10.1016\/j.cca.2023.117323_b0190","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2022"},{"key":"10.1016\/j.cca.2023.117323_b0195","article-title":"ggplot2: An Implementation of the Grammar of","author":"Wickham","year":"2015","journal-title":"Graphics."},{"key":"10.1016\/j.cca.2023.117323_b0200","doi-asserted-by":"crossref","unstructured":"Jin D, Zhang R, Chen H, Li C. Aberrantly glycosylated integrin \u03b13\u03b21 is a unique urinary biomarker for the diagnosis of bladder cancer. Aging (Albany NY). 2020 Jun 13;12(11):10844-10862. doi: 10.18632\/aging.103297. Epub 2020 Jun 13. PMID: 32534450; PMCID: PMC7346044.","DOI":"10.18632\/aging.103297"},{"issue":"7","key":"10.1016\/j.cca.2023.117323_b0205","doi-asserted-by":"crossref","first-page":"e0219480","DOI":"10.1371\/journal.pone.0219480","article-title":"Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15\u20133 (CA15-3) in human plasma","volume":"14","author":"Ter\u00e4v\u00e4","year":"2019","journal-title":"PLoS One."},{"issue":"24","key":"10.1016\/j.cca.2023.117323_b0210","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.12659\/MSM.911518","article-title":"Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients","volume":"10","author":"He","year":"2018","journal-title":"Med Sci Monit."},{"key":"10.1016\/j.cca.2023.117323_b0215","doi-asserted-by":"crossref","unstructured":"Ricardo S, Marcos-Silva L, Pereira D, Pinto R, Almeida R, S\u00f6derberg O, Mandel U, Clausen H, Felix A, Lunet N, David L. Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours. Mol Oncol. 2015 Feb;9(2):503-12. doi: 10.1016\/j.molonc.2014.10.005. Epub 2014 Oct 22. PMID: 25454345; PMCID: PMC5528651.","DOI":"10.1016\/j.molonc.2014.10.005"},{"issue":"11","key":"10.1016\/j.cca.2023.117323_b0220","first-page":"765","article-title":"Relation of ME491\/CD63 gene and integrin alpha5 in the invasion and metastases of ovarian cancer","volume":"40","author":"Xia","year":"2005","journal-title":"Zhonghua Fu Chan Ke Za Zhi."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:08:27Z","timestamp":1757862507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123001250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":44,"alternative-id":["S0009898123001250"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117323","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant glycosylation of \u03b13 integrins as diagnostic markers in epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117323"}}